Sionc Pharmaceuticals is an API manufacturer based in India. It holds 2 active US drug master files and one valid CEP across a filed portfolio of 6 molecules. Its GMP standing is certified by MFDS (Korea) and EMA. Customs aggregates show $5.8M of exports covering 103 molecules to 27 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Visakhapatnam, India | Not on file |
| Thanam (Village), IDA Parawada, Visakhapatnam-531021, Andhra Pradesh, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Vigabatrin | EDQM, US FDA | 3 |
| Bendamustine | SFDA (Saudi Arabia) | 1 |
| Cladribine | SFDA (Saudi Arabia) | 1 |
| Clofarabine | SFDA (Saudi Arabia) | 1 |
| Nelarabine | SFDA (Saudi Arabia) | 1 |
| Palbociclib | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | 5 | None |
| MFDS (Korea) | None | 2 |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.8M | 15 |
| 2025 | Not reported | $5.8M | 27 |
| 2024 | Not reported | $7.2M | 19 |
| 2023 | Not reported | $7.3M | 23 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Sionc Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free